BlackRock Inc. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$116,194,000
-46.1%
5,763,585
-0.2%
0.00%
-50.0%
Q2 2021$215,543,000
+37.8%
5,775,534
-5.6%
0.01%
+20.0%
Q1 2021$156,417,000
+17.7%
6,117,166
+1.4%
0.01%
+25.0%
Q4 2020$132,944,000
+27.4%
6,034,729
+4.1%
0.00%0.0%
Q3 2020$104,323,000
-30.8%
5,798,854
-2.3%
0.00%
-33.3%
Q2 2020$150,731,000
+62.2%
5,934,280
+17.3%
0.01%
+20.0%
Q1 2020$92,926,000
-4.8%
5,058,547
+14.1%
0.01%
+25.0%
Q4 2019$97,661,000
+55.7%
4,433,090
+1.5%
0.00%
+33.3%
Q3 2019$62,704,000
-6.8%
4,366,493
+2.2%
0.00%0.0%
Q2 2019$67,285,000
+7.7%
4,272,060
+0.2%
0.00%0.0%
Q1 2019$62,462,000
+34.9%
4,263,619
-1.6%
0.00%
+50.0%
Q4 2018$46,300,000
+2.3%
4,331,228
+46.0%
0.00%0.0%
Q3 2018$45,277,000
+41.7%
2,967,073
+13.8%
0.00%
+100.0%
Q2 2018$31,946,000
+1104.6%
2,607,895
+839.8%
0.00%
Q1 2018$2,652,000
+150.2%
277,493
+136.5%
0.00%
Q4 2017$1,060,000
+62.6%
117,321
+3.5%
0.00%
Q3 2017$652,000
+79.1%
113,396
-1.5%
0.00%
Q2 2017$364,000
-17.8%
115,065
-11.8%
0.00%
Q1 2017$443,000
+6228.6%
130,453
+5679.9%
0.00%
Q4 2016$7,000
-69.6%
2,257
-41.7%
0.00%
Q3 2016$23,000
+91.7%
3,8740.0%0.00%
Q2 2016$12,000
+1100.0%
3,874
+1693.5%
0.00%
Q1 2016$1,000
-99.7%
216
-98.3%
0.00%
-100.0%
Q1 2014$356,00012,6000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders